Novel regions associated with fibrinogen in single-variant test
| SNP . | CHR . | POS (b38) . | EA . | NEA . | EAF . | β∗ . | SE . | P value . | Q P value . | No. (samples) . | Direction . | Gene region . | Top variant consequence . | de Vries et al 2015 . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β∗ . | P value . | R2 . | ||||||||||||||
| rs149290349 | 2 | 43 224 818 | A | G | 0.068 | 0.036 | 0.005 | 9.62E-12 | .102 | 163 060 | +−−+ | ZFP36L2; THADA; PLEKHH2 | Missense (ZFP36L2) | 0.008 | 9.70E-06 | 0.87 |
| rs60064064 | 2 | 233 460 824 | A | G | 0.089 | −0.028 | 0.005 | 3.90E-09 | .018 | 150 506 | −−+− | SAG; DGKD; USP40 | Intronic (DGKD) | −0.004 | 8.26E-03 | 0.90 |
| rs35053471 | 3 | 47 083 271 | A | T | 0.365 | 0.018 | 0.003 | 1.55E-10 | .873 | 163 912 | ++++ | CCDC12; NBEAL2; SETD2 | Intronic (SETD2) | 0.005 | 5.61E-07 | 0.86 |
| rs10936662 | 3 | 170 860 674 | A | T | 0.169 | 0.022 | 0.004 | 6.81E-10 | .408 | 163 912 | ++−+ | RPL22L1; EIF5A2; SLC2A2 | Intergenic | 0.005 | 2.18E-04 | 0.91 |
| rs4565087 | 4 | 38 761 482 | C | T | 0.369 | 0.017 | 0.003 | 1.97E-09 | .782 | 157 981 | ++−+ | KLF3; TLR10; TLR1; TLR6 | Intergenic | 0.005 | 2.75E-07 | 0.92 |
| rs157512 | 5 | 56 513 300 | C | T | 0.238 | 0.022 | 0.003 | 2.13E-12 | .140 | 163 912 | ++++ | LINC01948; C5orf67 | Intronic (C5orf67) | 0.004 | 4.66E-04 | 0.97 |
| rs9376090 | 6 | 135 090 090 | C | T | 0.235 | −0.019 | 0.003 | 1.63E-09 | .622 | 147 776 | −−−− | HBS1L | Intergenic | −0.005 | 4.97E-06 | 0.98 |
| rs6470350 | 8 | 125 315 303 | G | A | 0.511 | 0.019 | 0.003 | 1.91E-11 | .281 | 148 283 | ++−+ | NSMCE2 | Intronic | 0.004 | 6.15E-05 | 0.99 |
| rs1543725 | 10 | 30 409 944 | A | G | 0.408 | 0.018 | 0.003 | 1.35E-10 | .713 | 161 181 | ++++ | CCND3P1; MAP3K8 | Intergenic | 0.004 | 3.50E-05 | 0.94 |
| rs7298698 | 12 | 103 127 106 | C | T | 0.481 | 0.019 | 0.003 | 1.99E-12 | .463 | 161 688 | +−++ | AC068643; C12orf42 | Intronic (C12orf42) | 0.005 | 1.29E-07 | 0.99 |
| rs2239222 | 14 | 72 545 177 | G | A | 0.376 | −0.018 | 0.003 | 1.53E-10 | .002 | 147 776 | −−−− | RGS6 | Intronic (RGS6) | −0.005 | 4.79E-07 | 0.95 |
| rs17580 | 14 | 94 380 925 | A | T | 0.039 | 0.045 | 0.007 | 3.70E-10 | .291 | 163 770 | ++−+ | SERPINA6; SERPINA1 | Missense (SERPINA1) | 0.011 | 6.56E-07 | 0.70 |
| rs4334315 | 16 | 79 722 300 | T | A | 0.303 | 0.020 | 0.003 | 2.21E-11 | .723 | 163 912 | ++++ | LINC01229; MAFTRR | Intronic (LINC01229 and MAFTRR) | 0.005 | 2.84E-06 | 0.83 |
| rs11077357 | 17 | 78 347 520 | C | G | 0.767 | 0.023 | 0.004 | 1.35E-10 | .706 | 147 384 | ++−+ | SOCS3 | Intergenic | 0.006 | 7.41E-04 | 0.49 |
| rs7507218 | 19 | 18 525 110 | A | G | 0.220 | 0.020 | 0.003 | 1.04E-09 | .568 | 163 909 | ++++ | SSBP4; ISYNA1; ELL; FKBP8 | Intergenic | 0.004 | 6.68E-04 | 0.92 |
| rs1672981 | 19 | 35 056 147 | C | T | 0.916 | 0.034 | 0.005 | 4.07E-10 | .136 | 148 280 | +−++ | HPN; HPN-AS1 | Intronic (HPN) | 0.007 | 2.48E-04 | 0.95 |
| rs34934360 | 19 | 45 895 731 | G | A | 0.112 | −0.027 | 0.004 | 2.79E-10 | .996 | 150 507 | −−−− | FOXA3; IRF2BP1; MYPOP; NANOS2 | Intronic (MYPOP) | −0.007 | 4.37E-07 | 0.90 |
| rs1415771 | 20 | 35 146 690 | A | G | 0.471 | −0.017 | 0.003 | 1.20E-09 | .441 | 147 776 | −−−− | EDEM2; PROCR | Intronic (EDEM2) | −0.002 | 3.38E-02 | 1.00 |
| SNP . | CHR . | POS (b38) . | EA . | NEA . | EAF . | β∗ . | SE . | P value . | Q P value . | No. (samples) . | Direction . | Gene region . | Top variant consequence . | de Vries et al 2015 . | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β∗ . | P value . | R2 . | ||||||||||||||
| rs149290349 | 2 | 43 224 818 | A | G | 0.068 | 0.036 | 0.005 | 9.62E-12 | .102 | 163 060 | +−−+ | ZFP36L2; THADA; PLEKHH2 | Missense (ZFP36L2) | 0.008 | 9.70E-06 | 0.87 |
| rs60064064 | 2 | 233 460 824 | A | G | 0.089 | −0.028 | 0.005 | 3.90E-09 | .018 | 150 506 | −−+− | SAG; DGKD; USP40 | Intronic (DGKD) | −0.004 | 8.26E-03 | 0.90 |
| rs35053471 | 3 | 47 083 271 | A | T | 0.365 | 0.018 | 0.003 | 1.55E-10 | .873 | 163 912 | ++++ | CCDC12; NBEAL2; SETD2 | Intronic (SETD2) | 0.005 | 5.61E-07 | 0.86 |
| rs10936662 | 3 | 170 860 674 | A | T | 0.169 | 0.022 | 0.004 | 6.81E-10 | .408 | 163 912 | ++−+ | RPL22L1; EIF5A2; SLC2A2 | Intergenic | 0.005 | 2.18E-04 | 0.91 |
| rs4565087 | 4 | 38 761 482 | C | T | 0.369 | 0.017 | 0.003 | 1.97E-09 | .782 | 157 981 | ++−+ | KLF3; TLR10; TLR1; TLR6 | Intergenic | 0.005 | 2.75E-07 | 0.92 |
| rs157512 | 5 | 56 513 300 | C | T | 0.238 | 0.022 | 0.003 | 2.13E-12 | .140 | 163 912 | ++++ | LINC01948; C5orf67 | Intronic (C5orf67) | 0.004 | 4.66E-04 | 0.97 |
| rs9376090 | 6 | 135 090 090 | C | T | 0.235 | −0.019 | 0.003 | 1.63E-09 | .622 | 147 776 | −−−− | HBS1L | Intergenic | −0.005 | 4.97E-06 | 0.98 |
| rs6470350 | 8 | 125 315 303 | G | A | 0.511 | 0.019 | 0.003 | 1.91E-11 | .281 | 148 283 | ++−+ | NSMCE2 | Intronic | 0.004 | 6.15E-05 | 0.99 |
| rs1543725 | 10 | 30 409 944 | A | G | 0.408 | 0.018 | 0.003 | 1.35E-10 | .713 | 161 181 | ++++ | CCND3P1; MAP3K8 | Intergenic | 0.004 | 3.50E-05 | 0.94 |
| rs7298698 | 12 | 103 127 106 | C | T | 0.481 | 0.019 | 0.003 | 1.99E-12 | .463 | 161 688 | +−++ | AC068643; C12orf42 | Intronic (C12orf42) | 0.005 | 1.29E-07 | 0.99 |
| rs2239222 | 14 | 72 545 177 | G | A | 0.376 | −0.018 | 0.003 | 1.53E-10 | .002 | 147 776 | −−−− | RGS6 | Intronic (RGS6) | −0.005 | 4.79E-07 | 0.95 |
| rs17580 | 14 | 94 380 925 | A | T | 0.039 | 0.045 | 0.007 | 3.70E-10 | .291 | 163 770 | ++−+ | SERPINA6; SERPINA1 | Missense (SERPINA1) | 0.011 | 6.56E-07 | 0.70 |
| rs4334315 | 16 | 79 722 300 | T | A | 0.303 | 0.020 | 0.003 | 2.21E-11 | .723 | 163 912 | ++++ | LINC01229; MAFTRR | Intronic (LINC01229 and MAFTRR) | 0.005 | 2.84E-06 | 0.83 |
| rs11077357 | 17 | 78 347 520 | C | G | 0.767 | 0.023 | 0.004 | 1.35E-10 | .706 | 147 384 | ++−+ | SOCS3 | Intergenic | 0.006 | 7.41E-04 | 0.49 |
| rs7507218 | 19 | 18 525 110 | A | G | 0.220 | 0.020 | 0.003 | 1.04E-09 | .568 | 163 909 | ++++ | SSBP4; ISYNA1; ELL; FKBP8 | Intergenic | 0.004 | 6.68E-04 | 0.92 |
| rs1672981 | 19 | 35 056 147 | C | T | 0.916 | 0.034 | 0.005 | 4.07E-10 | .136 | 148 280 | +−++ | HPN; HPN-AS1 | Intronic (HPN) | 0.007 | 2.48E-04 | 0.95 |
| rs34934360 | 19 | 45 895 731 | G | A | 0.112 | −0.027 | 0.004 | 2.79E-10 | .996 | 150 507 | −−−− | FOXA3; IRF2BP1; MYPOP; NANOS2 | Intronic (MYPOP) | −0.007 | 4.37E-07 | 0.90 |
| rs1415771 | 20 | 35 146 690 | A | G | 0.471 | −0.017 | 0.003 | 1.20E-09 | .441 | 147 776 | −−−− | EDEM2; PROCR | Intronic (EDEM2) | −0.002 | 3.38E-02 | 1.00 |
CHR, chromosome; direction, effect direction from CHARGE EUR only, CHARGE AFR only, CHARGE HIS only, and TOPMed; EA, effect allele; EAF, effect allele frequency; NEA, noneffect allele; POS (b38), position in build 38; R2, imputation quality.
∗Absolute value of effect sizes (β) is not comparable between this study and de Vries et al due to differences in trait transformations before GWAS; deVries et al sample size = 120 246 (mean = 118 670, minimum = 102 767).